![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PBXIP1 |
Gene summary for PBXIP1 |
![]() |
Gene information | Species | Human | Gene symbol | PBXIP1 | Gene ID | 57326 |
Gene name | PBX homeobox interacting protein 1 | |
Gene Alias | HPIP | |
Cytomap | 1q21.3 | |
Gene Type | protein-coding | GO ID | GO:0001501 | UniProtAcc | Q96AQ6 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
57326 | PBXIP1 | HTA11_3410_2000001011 | Human | Colorectum | AD | 4.62e-05 | 1.65e-01 | 0.0155 |
57326 | PBXIP1 | HTA11_2487_2000001011 | Human | Colorectum | SER | 3.25e-02 | 1.28e-01 | -0.1808 |
57326 | PBXIP1 | HTA11_1938_2000001011 | Human | Colorectum | AD | 4.24e-11 | 4.08e-01 | -0.0811 |
57326 | PBXIP1 | HTA11_347_2000001011 | Human | Colorectum | AD | 3.63e-12 | 2.56e-01 | -0.1954 |
57326 | PBXIP1 | HTA11_3361_2000001011 | Human | Colorectum | AD | 4.17e-09 | 2.96e-01 | -0.1207 |
57326 | PBXIP1 | HTA11_83_2000001011 | Human | Colorectum | SER | 9.83e-05 | 3.52e-01 | -0.1526 |
57326 | PBXIP1 | HTA11_696_2000001011 | Human | Colorectum | AD | 5.54e-08 | 2.47e-01 | -0.1464 |
57326 | PBXIP1 | HTA11_866_2000001011 | Human | Colorectum | AD | 4.36e-05 | 2.57e-01 | -0.1001 |
57326 | PBXIP1 | HTA11_1391_2000001011 | Human | Colorectum | AD | 7.88e-08 | 2.66e-01 | -0.059 |
57326 | PBXIP1 | HTA11_2992_2000001011 | Human | Colorectum | SER | 2.68e-04 | 2.44e-01 | -0.1706 |
57326 | PBXIP1 | HTA11_866_3004761011 | Human | Colorectum | AD | 6.58e-15 | 3.22e-01 | 0.096 |
57326 | PBXIP1 | HTA11_10711_2000001011 | Human | Colorectum | AD | 2.45e-09 | 2.77e-01 | 0.0338 |
57326 | PBXIP1 | HTA11_7696_3000711011 | Human | Colorectum | AD | 3.60e-11 | 3.05e-01 | 0.0674 |
57326 | PBXIP1 | HTA11_6818_2000001011 | Human | Colorectum | AD | 1.65e-04 | 4.61e-01 | 0.0112 |
57326 | PBXIP1 | HTA11_6818_2000001021 | Human | Colorectum | AD | 1.22e-04 | 2.56e-01 | 0.0588 |
57326 | PBXIP1 | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 1.29e-05 | 8.05e-01 | 0.3487 |
57326 | PBXIP1 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 2.33e-07 | 3.47e-01 | 0.3859 |
57326 | PBXIP1 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 3.08e-02 | 1.56e-01 | 0.2585 |
57326 | PBXIP1 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 5.86e-07 | 2.31e-01 | 0.3005 |
57326 | PBXIP1 | LZE4T | Human | Esophagus | ESCC | 1.29e-04 | 2.01e-01 | 0.0811 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0051098 | Colorectum | AD | regulation of binding | 126/3918 | 363/18723 | 6.01e-10 | 4.88e-08 | 126 |
GO:0022411 | Colorectum | AD | cellular component disassembly | 147/3918 | 443/18723 | 8.53e-10 | 6.76e-08 | 147 |
GO:0043087 | Colorectum | AD | regulation of GTPase activity | 110/3918 | 348/18723 | 1.64e-06 | 5.03e-05 | 110 |
GO:0030111 | Colorectum | AD | regulation of Wnt signaling pathway | 102/3918 | 328/18723 | 8.51e-06 | 2.03e-04 | 102 |
GO:0016055 | Colorectum | AD | Wnt signaling pathway | 130/3918 | 444/18723 | 1.60e-05 | 3.37e-04 | 130 |
GO:0198738 | Colorectum | AD | cell-cell signaling by wnt | 130/3918 | 446/18723 | 2.02e-05 | 4.10e-04 | 130 |
GO:0030177 | Colorectum | AD | positive regulation of Wnt signaling pathway | 45/3918 | 140/18723 | 1.23e-03 | 1.09e-02 | 45 |
GO:00224111 | Colorectum | SER | cellular component disassembly | 114/2897 | 443/18723 | 1.17e-08 | 9.59e-07 | 114 |
GO:00510981 | Colorectum | SER | regulation of binding | 97/2897 | 363/18723 | 1.98e-08 | 1.43e-06 | 97 |
GO:00160551 | Colorectum | SER | Wnt signaling pathway | 97/2897 | 444/18723 | 2.02e-04 | 3.68e-03 | 97 |
GO:01987381 | Colorectum | SER | cell-cell signaling by wnt | 97/2897 | 446/18723 | 2.39e-04 | 4.11e-03 | 97 |
GO:00301111 | Colorectum | SER | regulation of Wnt signaling pathway | 75/2897 | 328/18723 | 2.47e-04 | 4.20e-03 | 75 |
GO:00430871 | Colorectum | SER | regulation of GTPase activity | 77/2897 | 348/18723 | 5.90e-04 | 8.07e-03 | 77 |
GO:00510982 | Colorectum | MSS | regulation of binding | 113/3467 | 363/18723 | 3.55e-09 | 2.41e-07 | 113 |
GO:00224112 | Colorectum | MSS | cellular component disassembly | 130/3467 | 443/18723 | 1.44e-08 | 8.46e-07 | 130 |
GO:00301112 | Colorectum | MSS | regulation of Wnt signaling pathway | 98/3467 | 328/18723 | 3.37e-07 | 1.36e-05 | 98 |
GO:00160552 | Colorectum | MSS | Wnt signaling pathway | 124/3467 | 444/18723 | 6.06e-07 | 2.26e-05 | 124 |
GO:01987382 | Colorectum | MSS | cell-cell signaling by wnt | 124/3467 | 446/18723 | 7.83e-07 | 2.77e-05 | 124 |
GO:00430872 | Colorectum | MSS | regulation of GTPase activity | 101/3467 | 348/18723 | 1.00e-06 | 3.46e-05 | 101 |
GO:00301771 | Colorectum | MSS | positive regulation of Wnt signaling pathway | 44/3467 | 140/18723 | 1.57e-04 | 2.28e-03 | 44 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PBXIP1 | SNV | Missense_Mutation | rs751951283 | c.496N>A | p.Glu166Lys | p.E166K | Q96AQ6 | protein_coding | tolerated(0.45) | benign(0.124) | TCGA-44-7662-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
PBXIP1 | SNV | Missense_Mutation | rs372206354 | c.973N>T | p.Arg325Trp | p.R325W | Q96AQ6 | protein_coding | deleterious(0) | possibly_damaging(0.681) | TCGA-49-6761-01 | Lung | lung adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
PBXIP1 | SNV | Missense_Mutation | c.1027G>A | p.Ala343Thr | p.A343T | Q96AQ6 | protein_coding | deleterious(0.03) | possibly_damaging(0.544) | TCGA-55-6983-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | chemo | CR | |
PBXIP1 | SNV | Missense_Mutation | c.1026G>T | p.Glu342Asp | p.E342D | Q96AQ6 | protein_coding | deleterious(0.01) | benign(0.385) | TCGA-55-6983-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | chemo | CR | |
PBXIP1 | SNV | Missense_Mutation | c.1498N>A | p.Glu500Lys | p.E500K | Q96AQ6 | protein_coding | tolerated(0.08) | benign(0.027) | TCGA-55-8514-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
PBXIP1 | SNV | Missense_Mutation | c.1231N>T | p.Asp411Tyr | p.D411Y | Q96AQ6 | protein_coding | deleterious(0) | probably_damaging(0.961) | TCGA-62-A46O-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
PBXIP1 | SNV | Missense_Mutation | novel | c.1550G>C | p.Trp517Ser | p.W517S | Q96AQ6 | protein_coding | tolerated(0.06) | benign(0.219) | TCGA-78-8662-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
PBXIP1 | SNV | Missense_Mutation | c.874N>G | p.Gln292Glu | p.Q292E | Q96AQ6 | protein_coding | deleterious(0) | probably_damaging(0.913) | TCGA-80-5611-01 | Lung | lung adenocarcinoma | Male | Unknown | I/II | Unknown | Unknown | SD | |
PBXIP1 | SNV | Missense_Mutation | rs202026941 | c.847C>T | p.Arg283Trp | p.R283W | Q96AQ6 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-21-1075-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
PBXIP1 | SNV | Missense_Mutation | rs760022387 | c.965C>T | p.Ala322Val | p.A322V | Q96AQ6 | protein_coding | tolerated(0.07) | benign(0.185) | TCGA-34-2596-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |